2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients Developed in Collaboration With and Endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS)
Members W, Shah MJ, Silka MJ, Silva J, Balaji S, Beach C, Benjamin M, Berul C, Cannon B, Cecchin F, Cohen M, Dalal A, Dechert B, Foster A, Gebauer R, Corcia M, Kannankeril J, Karpawich P, Kim J, Krishna MR, Kubuš P, LaPage M, Mah D, Malloy-Walton L, Miyazaki A, Motonaga K, Niu M, Olen M, Paul T, Rosenthal E, Saarel E, Silvetti MS, Stephenson E, Tan R, Triedman J, Von Bergen N, Wackel P. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients Developed in Collaboration With and Endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). JACC Clinical Electrophysiology 2021, 7: 1437-1472. PMID: 34794667, DOI: 10.1016/j.jacep.2021.07.009.Peer-Reviewed Original ResearchConceptsAsia Pacific Heart Rhythm SocietyHeart Rhythm SocietyLatin American Heart Rhythm SocietyAmerican Heart AssociationCardiovascular implantable electronic devicesExpert consensus statementPediatric patientsImplantable electronic devicesHeart AssociationConsensus statementEuropean PaediatricAmerican CollegeCongenital cardiologyWriting committee membersRare disease entityClass of recommendationLevel of evidenceSpecific disease categoriesYears of ageConsensus expert opinionMiddle-income countriesScience AdvisoryClinical trialsDisease entityPractice guidelines